Literature DB >> 7357795

Intranasal and oral cocaine kinetics.

P Wilkinson, C Van Dyke, P Jatlow, P Barash, R Byck.   

Abstract

Plasma cocaine levels were determined in 7 subjects after intranasal and oral cocaine. Intranasal doses of 0.19, 0.38, 0.75, 1.5, and 2.0 mg/kg were given as a 10% aqueous solution; 0.38 mg/kg was given as crystalline cocaine HCl. Oral cocaine was administered in doses of 2.0 and 3.0 mg/kg. Intranasal cocaine kinetics were described by a 1-compartment open model with 2 consecutive first-order input steps and first-order elimination. Oral cocaine disposition was described by a 1-compartment open model with a lag time followed by a single first-order input phase and first-order elimination. The mean elimination half-life (t 1/2) for cocaine by the intranasal route to 7 subjects was 75 +/- 5 min (mean +/- SE). The mean t 1/2 after oral administration to 4 subjects was 48 +/- 3 min. The relative bioavailability [as determined by the area under the concentration-time curve (AUC)] for the 2.0-mg/kg dose by the intranasal and oral routes was not different. There was a linear increase in AUC with increasing intranasal dose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357795     DOI: 10.1038/clpt.1980.52

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  21 in total

Review 1.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

2.  Model of disposition of drugs administered into the human nasal cavity.

Authors:  I Gonda; E Gipps
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

3.  Does cocaine still have a role in nasal surgery?

Authors:  F Latorre; L Klimek
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 4.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

5.  Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

Authors:  María Elena Bravo-Gómez; Laura Nayeli Camacho-García; Luz Alejandra Castillo-Alanís; Miguel Ángel Mendoza-Meléndez; Alejandra Quijano-Mateos
Journal:  Toxicol Res (Camb)       Date:  2019-03-13       Impact factor: 3.524

6.  Topical nasopharyngeal anaesthesia with vasoconstriction in preeclampsia-eclampsia.

Authors:  B K Mokriski; A M Malinow; W C Gray; W J McGuinn
Journal:  Can J Anaesth       Date:  1988-11       Impact factor: 5.063

7.  Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene.

Authors:  E F McCance-Katz; L H Price; C J McDougle; T R Kosten; J E Black; P I Jatlow
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Improved performance 4 hours after cocaine.

Authors:  R Stillman; R T Jones; D Moore; J Walker; S Welm
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Simultaneous determination of L-tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: application in clinical studies.

Authors:  Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-20       Impact factor: 3.205

10.  Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans.

Authors:  Joshua A Lile; William W Stoops; Timothy S Allen; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.